Chevallard Daniel R.'s Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Mar 30, 2026
- Accession no.
- 0001706176-26-000004
- Filed
- Mar 30, 2026
- Trade date
- Mar 27, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $64.3K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chevallard Daniel R.CIK 0001706176 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Common Stock | PPurchaseAcquired | +7,500 | $8.57 | +$64,275 | 12,886 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.